[go: up one dir, main page]

HK1052012A1 - 16, 17-Carbocyclic condensed steroid compounds having selective estrogenic activity. - Google Patents

16, 17-Carbocyclic condensed steroid compounds having selective estrogenic activity.

Info

Publication number
HK1052012A1
HK1052012A1 HK03104310A HK03104310A HK1052012A1 HK 1052012 A1 HK1052012 A1 HK 1052012A1 HK 03104310 A HK03104310 A HK 03104310A HK 03104310 A HK03104310 A HK 03104310A HK 1052012 A1 HK1052012 A1 HK 1052012A1
Authority
HK
Hong Kong
Prior art keywords
alkenyl
alkyl
alkynyl
group
mdash
Prior art date
Application number
HK03104310A
Other languages
English (en)
Inventor
Hubert Jan Jozef Loozen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HK1052012A1 publication Critical patent/HK1052012A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK03104310A 2000-06-06 2003-06-17 16, 17-Carbocyclic condensed steroid compounds having selective estrogenic activity. HK1052012A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201986 2000-06-06
PCT/EP2001/004868 WO2002000682A1 (en) 2000-06-06 2001-05-01 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity

Publications (1)

Publication Number Publication Date
HK1052012A1 true HK1052012A1 (en) 2003-08-29

Family

ID=8171601

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03104310A HK1052012A1 (en) 2000-06-06 2003-06-17 16, 17-Carbocyclic condensed steroid compounds having selective estrogenic activity.

Country Status (27)

Country Link
US (3) US7868193B2 (de)
EP (1) EP1294739B1 (de)
JP (1) JP5095902B2 (de)
KR (1) KR100769865B1 (de)
CN (1) CN1235908C (de)
AR (1) AR028080A1 (de)
AT (1) ATE293124T1 (de)
AU (2) AU5838601A (de)
BR (1) BR0111445A (de)
CA (1) CA2410220C (de)
CZ (1) CZ20024014A3 (de)
DE (1) DE60110069T2 (de)
DK (1) DK1294739T3 (de)
ES (1) ES2240454T3 (de)
HK (1) HK1052012A1 (de)
HU (1) HUP0301190A3 (de)
IL (1) IL152957A0 (de)
MX (1) MXPA02012117A (de)
NO (1) NO324247B1 (de)
PE (1) PE20020214A1 (de)
PL (1) PL203732B1 (de)
PT (1) PT1294739E (de)
RU (1) RU2255090C2 (de)
SK (1) SK286852B6 (de)
TW (1) TWI225068B (de)
WO (1) WO2002000682A1 (de)
ZA (1) ZA200209452B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201109346A (en) * 2009-06-10 2011-03-16 Organon Nv Substituted 16,17-annellated steroid compounds for use in women's healthcare
US8367648B2 (en) 2009-06-10 2013-02-05 Msd Oss B.V. Substituted 16,17-annellated steroid compounds for use in womens healthcare

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194821A (en) * 1963-12-30 1965-07-13 Abbott Lab 17alpha-substituted 17beta-hydroxyestrenes
CA2200423C (en) 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor
IL123195A (en) * 1997-02-21 2002-11-10 Akzo Nobel Nv Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
DE60110069T2 (de) 2005-09-22
HUP0301190A2 (hu) 2003-08-28
CA2410220A1 (en) 2002-01-03
CN1433426A (zh) 2003-07-30
HUP0301190A3 (en) 2010-03-29
MXPA02012117A (es) 2003-06-06
WO2002000682A1 (en) 2002-01-03
SK17072002A3 (sk) 2003-06-03
US20100249083A1 (en) 2010-09-30
US7868193B2 (en) 2011-01-11
AR028080A1 (es) 2003-04-23
KR20030028752A (ko) 2003-04-10
DE60110069D1 (de) 2005-05-19
CN1235908C (zh) 2006-01-11
SK286852B6 (sk) 2009-06-05
AU5838601A (en) 2002-01-08
PL203732B1 (pl) 2009-11-30
JP2004501931A (ja) 2004-01-22
BR0111445A (pt) 2003-06-03
NO324247B1 (no) 2007-09-17
TWI225068B (en) 2004-12-11
IL152957A0 (en) 2003-06-24
ES2240454T3 (es) 2005-10-16
DK1294739T3 (da) 2005-08-01
CA2410220C (en) 2009-04-28
NO20025793L (no) 2002-12-02
AU2001258386B2 (en) 2005-08-18
EP1294739A1 (de) 2003-03-26
US20040102426A1 (en) 2004-05-27
PT1294739E (pt) 2005-06-30
ZA200209452B (en) 2004-02-20
NO20025793D0 (no) 2002-12-02
EP1294739B1 (de) 2005-04-13
PL359238A1 (en) 2004-08-23
ATE293124T1 (de) 2005-04-15
KR100769865B1 (ko) 2007-10-25
JP5095902B2 (ja) 2012-12-12
US20110224183A1 (en) 2011-09-15
CZ20024014A3 (cs) 2003-04-16
RU2255090C2 (ru) 2005-06-27
PE20020214A1 (es) 2002-03-13

Similar Documents

Publication Publication Date Title
PT1178045E (pt) Derivados de azaindole-etilamina como agentes de ligacao de receptores de acetilcolina nicotinicos
DK0582338T3 (da) 17-spiromethylensteroider
DK1446128T3 (da) Anvendelse af östrogenforbindelser i kombination med progestogenforbindelser i hormonsubstitutionsbehandling
ES2145915T3 (es) Derivados estereoquimicos de la wortmannina.
TR200002774T2 (tr) Alzheimer hastalığının tedavisi için steroit sapogenler ve bunların türevleri
ES2155566T3 (es) Uso de derivados de rifamicina para el tratamiento de enfermedades infecciosas por clamidia.
DE69523622D1 (de) Diastereomerenreine 3-oxo und 3-thioxo-4-aza-androstanderivate und ihre verwendung als antiandrogene
AR005672A1 (es) Derivados de la distamicina, proceso para prepararlos, y su utilizacion como agentes antitumorales y antivirales.
GB2380939B (en) Treatment or prevention of auto-immune diseases
ES2110260T3 (es) Androstenonas.
DE69841374D1 (de) 3-o-sulfamatsteroidderivate als hemmer von estronsulfatase
HK1052012A1 (en) 16, 17-Carbocyclic condensed steroid compounds having selective estrogenic activity.
BR0013769A (pt) Esteróides estrogênicos não aromáticos, composição farmacêutica, e, uso de um composto esteróide
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
HU9202100D0 (en) New 16-methyl-pregna-1,4-diene-3,20-dione derivatives
HK1061860A1 (en) 17 Alpha fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds
FI932446A0 (fi) 2b,19-metylaminobrosteroider som aromatasinhibitorer
EP1196428A4 (de) Durch 11-beta-aryl-17,17-spirothiolan substituierte steroide
NZ508228A (en) 2-aminopyrroline compounds characterised by presence of cyclopropyl group (e.g. N-(2-cyclopropylphenyl)-3,4-dihydro-2H-pyrrol-5-amine, N-(dicyclopropylmethyl)-3,4-dihydro-2H-pyrrol-5-amine or N-(2-cyclopropylphenyl)-2-methyl-3,4-dihydro-2H-pyrrol-5-amine for treating cardiovascular related diseases
ECSP014057A (es) Compuestos esteroides para la modificacion selectiva de la actividad de los receptores de estrogenos
RU2002135594A (ru) 16, 17-карбоциклические конденсированные стероидные соединения, обладающие селективной эстрогенной активностью
ATE339415T1 (de) Benzocarbazol und indenoindole derivate als östrogene agentien
MX9801428A (es) Compuestos esteroidales que tiene actividad anticonceptiva y anti-osteoporosis.
NZ333837A (en) estrene steroids for inducing hypothalamic effects

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110501